Public Workshop; Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies; March 24, 2015

The Food and Drug Administration (FDA), in co-sponsorship with American Association for Cancer Research (AACR) and American Society of Clinical Onocology (ASCO) is holding  a Public Workshop entitle, “ Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies”   The purpose of the workshop is to facilitate an in-depth discussion of harmonization of companion diagnostic devices across a class of targeted therapies.  The workshop aims to foster collaborations in the clinical cancer research community; provide a deeper understanding of anticancer drug and device development related to personalized medicine; provide a unique perspective of personalized medicine; and help incorporate emerging scientific findings to harmonize companion diagnostics across a class of targeted therapies.

This public workshop will be held on March 24, 2015 beginning at 8:30 a.m. Eastern time and will be held at:

Mayflower Hotel

Grand Ballroom

1127 Connecticut Avenue, NW

Washington, DC  20036

(202) 347-3000

For additional information on this workshop and registration, please see the FDA/CDRH meeting/workshop website at:http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm436716.htm

Thank you,

Food and Drug Administration

Center for Devices and Radiological Health